Office of Research & Development |
![]() ![]() |
Project Number: | I01BX002761-05 |
Title: | Claudin-3, Gut Dysbiosis and Inflammatory Bowel Disease |
Principal Investigator: | Amar B Singh |
Location: | Omaha, NE |
Congressional District Code: | 2 |
Research Service: | Biomedical Laboratory R&D |
Project Period: | April 2020 - March 2024 |
FY 2021 Funding Amount: | $263,878 |
Total Award Amount (all years): |
$1,239,216 |
Abstract: |
View full abstract and other project information on NIH RePORTER Go To NIH RePORTER Excerpt: Inflammatory bowel disease (IBD), consisting primarily of the ulcerative colitis (UC) and Crohn’s disease (CD), is a group of debilitating auto-immune disorders, which significantly affect one’s life-style and carry a high risk of colon cancer. While significant advances have been made in the clinical management of these diseases, the overall incidence rate and disease severity in active duty army personnel and veterans is constantly increasing possibly due to the high level of stress involved.... |